The decoration of secretory glycoproteins and glycolipids with sialic acid is critical to many physiological and pathological processes. Sialyation is dependent on a continuous supply of sialic acid into Golgi organelles in the form of CMP-sialic acid. Translocation of CMP-sialic acid into Golgi is carried out by the CMP-sialic acid transporter (CST). Mutations in human CST are linked to glycosylation disorders, and CST is important for glycopathway engineering, as it is critical for sialyation efficiency of therapeutic glycoproteins. The mechanism of how CMP-sialic acid is recognized and translocated across Golgi membranes in exchange for CMP is poorly understood. Here we have determined the crystal structure of a eukaryotic CMP-sialic acid transporter in complex with CMP. We conclude that the specificity of CST for CMP-sialic acid is established by the nucleotide CMP to such an extent, they are uniquely able to work both as passive and as (secondary) active antiporters.
Introduction
Sialic acids decorate the outermost ends of secreted and cell surface expressed glycoproteins and glycolipids 1, 2 . Terminal sialic acid linkages are vital for cellular recognition, immunology and communication 3 . The cell-surface display of sialic acid is also a receptor for interactions with viruses, such as Influenza and HIV 1, 4 . Sialic acid levels are also increased in cancer cells 5, 6 , which has led to the definition of sialic acids as potential therapeutic targets 7 . In the nucleus, sialic acid is activated to CMP-sialic acid, where it is delivered into the Golgi lumen by the action of the CMP-Sialic acid transporter (CST) 8, 9 (Fig. 1a ). CSTs belongs to the Solute Carrier SLC35 family of Nucleotide Sugar Transporters (NST), which in humans translocate seven other essential sugars into the ER and/or Golgi for glycosylation in the form of GDP-fucose, UDPgalactose, UDP-glucose, UDP-xylose, UPD-GlcNAc, UDP-GalNAc and UDP-GlcA 8, 10 . SLC35
activities are important to human physiology and have been associated with diseases such as obesity 11, 12 . SLC35 members can influence the efficacy of anti-cancer drugs 13 , and also transport UDP-glucuronic acid into the liver ER for glucuronidation 14 , which is an essential process for the metabolism of many drugs, e.g., analgesics, nonsteroidal anti-inflammatory agents, antipsychotics, antivirals, and benzodiazepines 15 .
A number of NST show overlapping substrate specificities 8, 16 , transporting the charged nucleotide-diphosphate sugar (G/UDP-sugar) in exchange for their counter nucleotide monophosphate, G/UMP. CMP-sialic acid transporters are atypical nucleotide-sugar transporters, as they are only found in Golgi organelles and transport sialic acid conjugated to a nucleotide monophosphate i.e., CMP-sialic acid is exchanged for CMP 8, 9, 17 . Several CST mutations have been linked to human pathologies 18 and congenital glycosylation disorders 19 . Since sialyation efficiency affects the therapeutic efficacy of many therapeutic glycoproteins 20, 21 , CST is also a promising candidate for glycoengineering, as it is the rate limiting factor in the sialyation of glycoproteins 22 . Recently, an outward-facing structure of a nucleotide-sugar transporter for the yeast GDP-mannose transporter (Vrg4) was reported 23 . However, GDP-mannose is only transported into either the ER or Golgi in non-mammalian organisms such as yeast 24 . Because of the large evolutionary gap between the GDP-mannose and CMP-sialic acid transporters 25 , the molecular basis for how activated sialic acid is transported into Golgi is still yet to be understood. Indeed, the poor structural and mechanistic understanding of SLC35 mediatedtransport in general, has hampered elucidating their role in human physiology and their targeting in drug development.
Results

Crystal structures of the human CMP-Sialic acid transporter homologue CSTZM
The CST homologue from Zea mays (CSTZM) with 28 % sequence identity to human, and ~80% sequence identity to an Arabidopsis thaliana CST capable of complementing CMP-sialic acid transport in the model Chinese Hamster Ovary cell line Lec2 26 , was identified by fluorescentbased screening methods 27, 28 as a suitable candidate for structural studies ( Supplementary Fig.   1a ). Consistently, binding studies using the GFP-Thermal Shift (GFP-TS) assay had shown that CSTZM was only significantly thermostabilized by CMP, and by none of the other nucleotidemonophosphates 29 . CMP binding affinities (Kd) of CSTZM and human CST (hCST) were further found to be similar to one another and consistent with Isothermal Titration Calorimetry measurements 29 . Indeed, we were able to confirm robust transport of CMP-sialic acid in CSTZM containing proteoliposomes comparable to hCST ( Fig. 1b ). Thus, we could establish CSTZM as a suitable model system to elucidate the molecular basis of human CMP-sialic acid transport.
CSTZM was crystallized by vapor diffusion and in meso (LCP) methods in the absence and presence of CMP, respectively (Methods). The CSTZM crystal structures were solved by molecular replacement (MR) and refined against data extending up to 3.4 Å and 2.8 Å, respectively ( Supplementary Fig. 1b , Supplementary Table 1 , and Methods). Both CSTZM structures were captured in an outward-facing conformation, which in a cellular context places the cavity open to the Golgi lumen for the binding of CMP ( Fig. 1a and 1c ). As expected from the low sequence identity, a comparison of CSTZM with the previous outward-facing structure of the GDP-mannose yeast transporter Vrg4 showed a large degree of structural difference, with an r.m.s.d. of 4.9 Å for 179 pairs of Cα atoms (Methods and Supplementary Fig. 2a ). The poor superimposition was also observed in the apo CSTZM and Vrg4 structures, which means that the structural differences were unlikely to be the consequence of binding different substrates (Methods and Supplementary Fig. 2b ). Rather, extensive re-positioning of TM3, TM6 and TM8, in particular, reshapes the outward-facing state to give uniquely different cavities for CSTZM and Vrg4 ( Fig. 1e and Supplementary Fig. 2a ).
Due to the destabilization of CSTZM by monoolein, LCP crystals could only be obtained in the presence of 1.2 mM CMP, which significantly stabilized the protein 29 . Consistently, an omit map showed strong positive density for CMP, which was absent in the apo CSTZM structure obtained by vapor diffusion crystals ( Supplementary Fig. 2a ). Unexpectedly, CMP binds at the peripheral end of the large cavity, between the helices TM2, TM3 and TM7 ( Fig. 1c-e ). The binding site for CMP shares no overlap with the position of GDP in the GDP-mannose bound structure of Vrg4, where the substrate binds more centrally and is coordinated by residues from TM1, TM7, TM8 and TM9 ( Fig. 1e and Supplementary Fig. 2 ). Rather, the repositioning of TMs in CSTZM creates a unique pocket for CMP not observed in Vrg4 ( Fig. 1e and Supplementary   Fig. 2a ). Reflecting their poor overall structural superimposition, the side-chain chemistry between the two proteins is highly divergent at the respective GDP-mannose and CMP binding sites ( Supplementary Fig. 3a-b ). Despite these differences, most residues surrounding CMP within the CST subfamily are highly conserved ( Supplementary Fig. 3c ).
Molecular recognition of CMP and CMP-sialic acid by CSTZM and human CST
Using the GFP-TS assay, we found that the addition of CMP increased the melting temperature (Tm) of CSTZM by ~7 ºC compared to only ~ 1º C for either UMP or sialic acid, and was hence used to measure substrate binding ( Supplementary Fig. 1c-d ). In the CSTZM structure, the nucleobase cytosine forms p-stacking interactions with Trp209 and hydrogen bonds to the carbonyl group of Asn86 ( Fig. 2a ). The ribose moiety is coordinated by hydrogen bonds to Ser79 and by van der Waals interactions to Leu83 and Phe205. The phosphate group is coordinated to the side chains of Glu42 and Try82 via highly ordered water molecules. With the exception of Ser79, single alanine mutants of these residues strongly reduced CMP binding (Fig. 2b ). The alanine mutants that completely abolished CMP binding were Tyr82, Asn86, and Trp209. Apart from Trp209, all these residues are strictly conserved in related SLC35 members, but are not conserved in Vrg4 at either the sequence or structural level ( Supplementary Fig. 3a-b and Supplementary Fig. 4a-b ). In support of their relevance to CST proteins, single alanine substitutions at equivalent positions in hCST also abolished CMP binding ( Fig. 2b ). As in CSTZM, the equivalent serine to alanine mutation in hCST (Ser95) showed robust binding. Thus, polar interactions with ribose do not appear critical for CMP binding, rather CMP binding appears to be primarily established through coordination of the phosphate and cytosine moieties.
In a surface representation of CSTZM, the phosphate moiety points towards a large patch of positively-charged electrostatic potential, which is a highly favorable interaction surface for the negatively charged sialic acid sugar ( Fig. 1c ). In addition to the waters interacting directly with the phosphate moiety, there is also a network of well-coordinated waters that extends from one end of the 23 Å cavity to the other ( Fig. 2a and Supplementary Fig. 3d ). Noticeably, crystallographic waters at the opposite end of the cavity to CMP are connected to well-conserved lysine residues, Lys108 and Lys262 ( Fig. 2a and Supplementary Fig. 4 ). Remarkably, lysine to alanine substitutions abolished CMP binding in CSTZM and in hCST the equivalent residue to Lys262 (Lys272) was abolished whilst Lys108 (Lys124) showed reduced binding ( Fig. 2b ). In comparison, alanine substitutions of the polar residues Asn106 and Ser267 located near these residues, but not interacting with these waters, retained robust CMP binding ( Supplementary Fig.   1e ). CMP is further connected to the bottom of the cavity through water-mediated contacts to Lys45 and Tyr199, which are conserved in hCST (Lys55, Tyr214) and were likewise found to be essential for binding ( Fig. 2b) . Thus, the binding of CMP is additionally coordinated by an intricate hydrogen-bonding network of waters and charged groups.
One would expect that the binding site for CMP and for CMP when it is conjugated with sialic acid to be equivalent. To confirm this assumption, single alanine mutants assessed for CMP binding were re-measured with CMP-sialic acid. Consistently, CMP and CMP-sialic acid binding profiles in both hCST and CSTZM proteins were almost identical ( Fig. 2c and Supplementary Fig. 1d ). This finding strongly suggests that the highly-coordinated waters next to the phosphate moiety likely represent the binding site of the sialic acid moiety when it is conjugated to CMP ( Fig. 2a ). Modelled in this position, the lysine residue Lys45 would be suitably located to interact directly with sialic acid, whereas Lys108 and Lys262 would indirectly coordinate the sialic acid moiety, but not the phosphate moiety itself ( Supplementary Fig. 5a ).
Notably, there is no obvious overlap in the sugar binding sites for sialic acid in CST and mannose in the GDP-mannose bound structure of Vrg4 ( Supplementary Fig. 2a ).
Dimerization and structural impact of human CST disease mutations
An overlay of the internal structural repeats in CSTZM shows that Lys108 and Lys262, along with the CMP binding residues Asn86 and Tyr82, are consistently located on the segments most likely to undergo local rearrangements in response to substrate binding ( Fig. 2f ) 30 . Furthermore, CSTZM homodimerizes in both crystal forms through extensive interactions between equivalent TM5 and TM10 helices, burying a total surface area of ~3.060Å 2 (Fig. 3a ). CSTZM appears to be forming two distinct domains, a dimerization domain and a transport domain. The transport domain bundles are held together on the cytoplasmic side through extensive polar interactions ( Supplementary Fig. 5b ). It is likely that the dimerization domain acts as a scaffold to support the transport domain bundles rearrangements, which are likely to be similar to that predicted for Vrg4 23 and structural homologues TPT 30,31 and YddG 32 .
CST are associated with Congenital disorders of glycosylation type 2f (CDG2f), which result in severe inherited diseases caused by under-sialyation of glycoproteins 18, 33, 34 . More specifically, heterozygous mutations Thr156Arg and Glu196Lys in CST have been shown to reduce CMPsialic acid transport into Golgi 18 . In a model of hCST based on CSTZM, Thr156 is located at the dimer interface and Glu196 is located at the cytoplasmic intracellular ionic network ( Fig. 3b ).
Using the GFP-TS assay we confirmed that the Thr156Arg and Glu196Lys mutations show close to wildtype binding of CMP and CMP-Sia, which means these mutations have not perturbed the hCST structure ( Fig. 3c ). Rather, CMP-Sialic acid transport by hCST was severely reduced in the Thr156Arg disease mutation and abolished in Glu196Lys ( Fig. 3c ). Thus, the disease mutations support the physiological importance of CST dimerization and the intracellular ionic network.
A chaperone-mediated nucleotide substrate selectivity mechanism
Although the positively charged binding site for sialic acid is highly favorable, it has been reported that "free" sialic acid does not compete for the transport of CMP-sialic acid 35 .
Consistently, we were unable to detect the binding of sialic acid to CSTZM and hCST proteins ( Fig. 2c and Supplementary Fig. 1d ). We think that the most likely reason is that the sialic acid moiety is unable to reach the deep binding pocket on its own. In agreement with this line of reasoning, the sialic acid binding pocket is situated below a large region of non-polar and negatively charged surfaces, which are highly conserved and conspicuously absent of crystallographic waters ( Fig. 1c and Supplementary Fig. 3c ). In support of a physical barrier for the passage of free sialic acid, we found that the binding affinities (Kd) for CMP-sialic acid (Kd = 1.5 to 3.1 mM) were significantly weaker than for CMP (Kd = 40 µM) ( Fig. 2d and Supplementary Fig. 1f ). Moreover, pre-steady state concentrations of unlabeled CMP competed significantly better for the uptake of radiolabeled [ 3 H]-CMP-sialic acid than equimolar amounts of unlabeled CMP-sialic acid ( Fig. 2e ).
It has been shown that the closely related UDP-galactose transporter (SLC35A2) ( Supplementary   Fig. 4a ), could be converted into a CMP-sialic acid transporter when their respective TM7 segments were swapped, with further enhancement in activity if TM2 and TM3 were also exchanged 36 . Consistently, we found that only residues from exactly these TMs coordinated CMP in the CSTZM structure ( Fig. 2a ). Based on the CSTZM structure, sugar binding residues are therefore unlikely to be altered by these chimera studies, which further implies that sugar recognition does not require strict coordination, but is likely to be flexible. Promiscuity could be important in vivo for other NST members too, since different sugars can be transported when coupled to the same nucleotide 37,38 . Additionally, the physiological substrate for CSTZM is likely to be CMP-Kdo, which is also an acidic sugar different yet structurally related to sialic acid 26 .
Taken together, we conclude that the specificity for CMP-sialic acid in CST is primarily established by its recognition of the CMP moiety.
Human CST and CSTZM can function both as a uniporter and an antiporter
It is well-established that NST function as antiporters, exchanging the cytosolic nucleotide-sugar for their corresponding nucleotide monophosphate 8, 34 . Most antiporters work by simple competition mechanism between structurally similar, yet distinct solute molecules 39 . This conceptually poses a problem in the NSTs however, as whilst the bi-partite molecule is matched with a bi-partite substrate-binding site, the counter substrate is only a competitor for one half of the transported solute. This "flaw" is most pronounced in CST, since CMP is transported in both directions with substrate recognition governed primarily by the nucleotide monophosphate.
Intriguingly, transport measurements in either isolated Golgi vesicles or proteoliposomes concluded that CST activities might be "leaky", because CMP-sialic acid uptake could be observed in the absence of vesicles pre-loaded with CMP 8, 17, 40 . Although compelling, highlevels of CMP-sialic acid uptake into empty vesicles has made it difficult to come to any firm conclusions regarding coupling. To investigate this observation more thoroughly, we used our proteoliposome transport assay that was extensively optimized to have very low background activity in either empty or inactive-mutant containing liposomes ( Fig. 1b and Fig. 2e ). As shown in Figure 4a , robust transport of [ 3 H]-CMP-sialic acid was indeed measurable in the absence of CMP. Transport of [ 3 H]-CMP-sialic acid was, however, highly stimulated when liposomes were preloaded with CMP, consistent with other studies and antiport activity (Fig. 4b) 17 . Remarkably, we found that transport of [ 3 H]-CMP (uptake) was also measurable in the absence of an outwardly-directed CMP-sialic acid gradient, consistent with a facilitator primarily recognizing the CMP moiety ( Supplementary Fig. 5c-d ).
Discussion
By a combination of crystal structures, binding and transport assays we conclude that the molecular recognition of CMP-sialic acid in CST is established primarily through the nucleotide monophosphate CMP. We further propose that sialic acid needs to be chaperoned into the deep binding site by CMP, which requires passage through a cavity that is very different to that seen in the GDP-mannose transporter Vrg4. Indeed, the Nucleotide Sugar Transporters appear to be adopting unique cavities to match the binding modes of the different substrates. While this is a common practice in GPCRs 41 , this level of divergence is unusual in transporters, which predominantly evolve only the side-chain chemistry to bind different substrates 39 . This specialization contributes to a nucleotide-mediated selectivity mechanism in CST, which might be to ensure that CMP-sialic acid is not inadvertently transported into the ER by the other nucleotide-sugar transporters, and would explain why CMP is specifically conjugated to sialic acid.
Nucleotide-sugar transporters are annotated as antiporters 8, 10, 23, 42 , but uniquely we conclude that CMP-sialic acid transporters are antiporters that can also function as facilitative transporters (uniporters) (Fig. 4c ). After substrate release, uniporters are able to spontaneously re-set themselves back to an opposite-facing conformation, whilst antiporters are unable to reset themselves until a counter-substrate has bound 39 . This distinction implies that the energetic barriers separating the alternating conformations in CMP-sialic acid transporters are lower than in other NSTs, which are mostly strict antiporters and are thought to bind their substrates with equal affinities 23 . From a physiological perspective, CMP efflux might be required to be uncoupled from CMP-sialic acid transport under some circumstances because low levels of CMP (Ki = 40 µM) is a potent inhibitor of siayltransferase activity in the Golgi 43,44 . Indeed, for some unknown reason CMP-sialic acid is synthesized in the nucleus while all other nucleotide-sugars are synthesized in the cytoplasm 8, 45 . The compartmentalization of CMP-sialic acid synthesis in the nucleus suggests that cytoplasmic levels of CMP-sialic acid are regulated, which could be further correlated with the different modes of transport seen in CST. Further investigation will clearly be required to solidify the physiological significance of the uncoupled CMP-sialic acid transport and to refine the conserved sugar and nucleotide recognition motifs for this diverse SLC35 transporter family. Nonetheless, the structure of CSTZM and comparative analysis with human CST provides a template for glycopathway engineering, a molecular explanation for their substrate recognition, and explains how they are uniquely able to transport in an energized and non-energized manner.
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Substrate specificity and binding analysis using GFP-TS
The GFP-TS method, which is derived from the FSEC-TS assay 49 , was used to screen for ligand binding as described previously 29 CMP binding affinities to detergent-solubilized hCST/CSTZM GFP fusion containing membranes were previously assessed using the GFP-TS assay 29 . To verify that these CMP binding affinities were comparable to those measured with purified hCST/CSTZM GFP fusions, the experiment was performed as described for CMP-sialic acid, except CMP was added to final concentrations of 0 to 2 mM and the protein concentration was adjusted to 5,000 RFU (0.04 µg.µl -1 ) in 20 mM Tris-HCL pH 7.5, 150 mM NaCl, and 0.03 % (w/v) DDM.
Analysis of the substrate-binding site
All CST mutants were synthesized as gene strings (Life Technologies) and were sub-cloned, overexpressed and membranes were isolated as described in the section Large-scale production and purification of CSTZM and hCST. Only hCST/CSTZM mutants with a monodisperse peak in DDM by FSEC 28 were assessed for their ability to bind CMP or CMP-sialic acid using the GFP-TS assay. The apparent Tm was determined in the absence and presence of compounds (CMP, UMP, CMP-sialic acid and sialic acid), as described for the substrate-specificity measurements.
All melting curves were fitted by non-linear regression using the software Prism. Each experiment was carried out in triplicate. The DTm was calculated by subtracting the absolute difference in the melting temperatures (Tm) in the presence and absence of listed compounds.
Because the binding affinities measured by the GFP-TS method were equivalent to binding affinities estimated by ITC 29 , the DTm values were considered a robust estimate of substratebinding efficiency. The comparative binding efficiency of mutants was calculated as fraction of WT DTm hCST/CSTZM values. Y98A and N102A mutants of hCST were purified as described for the wildtype and concentrated to ~3 mg.ml -1 for functional experiments.
Crystallization of CSTZM
The 
Data availability
The coordinates and the structure factors for CSTZM have been deposited in the Protein Data Bank with accession numbers 6I1R (CMP bound CSTZM structure) and 6I1Z (apo CSTZM structure). Further information and requests for resources and reagents should be directed to David Drew (ddrew@dbb.su.se). Asn86 involved in CMP-sialic acid binding are shown as sticks (colored as in Fig. 1d ).
Fig. 3| Dimerization and human CST glycosylation disease mutants. a, Cartoon
representation of the CSTZM homodimer, which is identical in both crystal forms (for sake of clarity only the dimer structure grown from LCP crystals is shown). In each protomer, dimerization is mediated by TM5 (cyan) and TM10 (wheat), which are connected via flexible loops to the transport bundles made up of TMs 3, 4, 6, and 7 (cyan) and TMs 1, 2, 8 and 9
(wheat). During structural transition from the outward to occluded conformation the extracellular half of TM 3 and 4 moves inwards (from residue Pro78 to Gly113) to gate substrate binding, as apparent from the asymmetry of these regions in a superimposition of the inverted-topology repeats (Fig. 2f) , which is consistent with what was previously described for other drugmetabolite superfamily (DMT) members 23, [30] [31] [32] . In contrast to other dimeric DMT structures 23, 30 , 25 homodimerization of CSTZM is more extensive and not mediated by any lipids. b, Cartoon representation of a modelled hCST protein (see Methods) depicting the location of mutations responsible for congenital disorders of glycosylation type 2f. c, CMP-sialic acid binding to hCST using hCST-GFP-fusions as determined by a shift in DTm after addition of either 1 mM CMP (black bars) or 10 mM CMP-sialic acid (pattern-filled bars) for WT, T156R and E196K mutants. Errors bars represent s.e.m. of 3 independent experiments. c, CST transporters operate by a rocking-switch alternating-access mechanism as they exchange CMP-sialic acid for CMP across the Golgi membrane using an antiport mechanism 39 . However, as the recognition for CMP-sialic acid is established primarily by CMP, they can also carry out factitive transport of CMP, which means they can operate both as passive and as active transporters.
